HC Wainwright Issues Optimistic Outlook for LPTX Earnings
Leap Therapeutics, Inc. (NASDAQ:LPTX – Free Report) – Analysts at HC Wainwright upped their Q2 2025 earnings per share (EPS) estimates for Leap Therapeutics in a research report issued on Wednesday, May 14th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.29) per share for the quarter, up from their previous […]
Leap Therapeutics, Inc. (NASDAQ:LPTX – Free Report) – Analysts at HC Wainwright upped their Q2 2025 earnings per share (EPS) estimates for Leap Therapeutics in a research report issued on Wednesday, May 14th. HC Wainwright analyst S. Ramakanth now forecasts that the company will earn ($0.29) per share for the quarter, up from their previous […]
